137: GLP Maintenance Dosing and Microdosing
Impossible d'ajouter les articles
Impossible d'ajouter le titre au panier.
Impossible d'ajouter le titre à la liste d'envies.
«Retirer de la liste d'envies» a échoué.
Échec de « Suivre le podcast »
Échec de «Ne plus suivre le podcast»
-
Lu par :
-
De :
We break down the real middle ground between staying on a full GLP-1 dose and stopping abruptly, using the “ladder, not a switch” mindset for long-term weight loss maintenance. We share what the newest evidence says about lower maintenance doses, spacing injections, tapering safely, and why DIY microdosing can create serious risks.
• the ladder approach to GLP-1 treatment decisions
• why stopping GLP-1s cold turkey often leads to regain and worsening blood sugar and blood pressure
• what Surmount Maintain suggests about low-dose tirzepatide maintenance after a plateau
• how maintenance dosing can preserve weight loss and improve A1C in people with prediabetes
• the pharmacology behind spacing injections and what early models and small case data show
• oral Wegovy dosing options, cost realities, and why access drives real-world choices
• slow tapering as a safer off-ramp while monitoring hunger and weight trend
• why microdosing by “click counting” lacks solid evidence and raises safety concerns
• how insurance coverage changes can force medication switches and disrupt continuity of care
You can find us on Threads, Instagram, or send us some fan mail. But most importantly, stay healthy, my friends.
Send us a (voice ) message with this link, we would love to hear from you. Standard message rates may apply.
Support the show
Production and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RN
Artwork Rebrand and Avatars:
Vantage Design Works (Vanessa Jones)
Website: https://www.vantagedesignworks.com/
Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qr
Original Artwork Concept: Olivia Pawlowski